1-14 of 14
Christopher Gocke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FLT3 inhibitors added to induction therapy induce deeper remissions

Clinical Trials & Observations
Mark Levis, Wenge Shi, Ken Chang, Christian Laing, Reinhold Pollner, Christopher Gocke, Emily Adams, Flora Berisha, Jelveh Lameh, Arnaud Lesegretain
Journal: Blood
Blood (2020) 135 (1): 75–78.
https://doi.org/10.1182/blood.2019002180
Published: 2020
Includes: Supplemental data
Journal Articles

The Cell of Origin in NPM1 Positive Acute Myeloid Leukemia (AML) Is Prognostic

Mark Iscoe, BA, Kelly J Norsworthy, MD, Gabriel Ghiaur, MD PhD, B. Douglas Smith, Christopher Gocke, MD, Richard J Jones, MD
Journal: Blood
Blood (2016) 128 (22): 1690.
https://doi.org/10.1182/blood.V128.22.1690.1690
Published: 2016
Journal Articles

A Randomized Phase II Trial of Interferon (IFN)/GM-CSF Versus K562/GM-CSF Vaccination in Chronic Phase CML Patients on Frontline Tyrosine Kinase Inhibitor (TKI) Therapy: Potential of IFN to Enhance Molecular Remissions

Jonathan Allen Webster, MD, Anna Ferguson, BSN, RN, Christopher Gocke, MD, Richard J Jones, MD, Hyam Levitsky, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2016) 128 (22): 3088.
https://doi.org/10.1182/blood.V128.22.3088.3088
Published: 2016
Journal Articles

Prospective Study of Peri-Transplant Use of Sorafenib As Remission Maintenance for FLT3-ITD Patients Undergoing Allogeneic Transplantation

Keith W. Pratz, MD, Ivana Gojo, MD, Judith E. Karp, MD, Leo Luznik, MD, B. Douglas Smith, MD, Richard J Jones, MD, Jackie Greer, RN, Christopher Gocke, MD, Maria R. Baer, MD, Vu H. Duong, MD, John J Wright, MD PhD, Michelle A. Rudek, PharmD, PhD, Ashkan Emadi, MD, PhD, Mark J. Levis, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3164.
https://doi.org/10.1182/blood.V126.23.3164.3164
Published: 2015
Journal Articles

A Germline Mutation in ERBB3 Predisposes to Inherited Erythroid Myelodysplasia/Erythroleukemia

Evan M. Braunstein, MD PhD, Ruijuan Li, Nara Sobreira, MD, Christopher Gocke, MD, Robert A. Brodsky, MD, David Valle, MD, Linzhao Cheng, PhD
Journal: Blood
Blood (2015) 126 (23): 4105.
https://doi.org/10.1182/blood.V126.23.4105.4105
Published: 2015
Journal Articles

Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML

Amy Sexauer, Alexander Perl, Xiaochuan Yang, Michael Borowitz, Christopher Gocke, Trivikram Rajkhowa, Christian Thiede, Mark Frattini, Grant E. Nybakken, Keith Pratz, Judith Karp, B. Douglas Smith, Mark Levis
Journal: Blood
Blood (2012) 120 (20): 4205–4214.
https://doi.org/10.1182/blood-2012-01-402545
Published: 2012
Includes: Supplemental data
Journal Articles

IGHV Mutational Status Is Prognostic in Del(11q) and Del(17p) Chronic Lymphocytic Leukemia

Douglas Edward Gladstone, MD, Amanda Blackford, Yvette L. Kasamon, Lode J. Swinnen, MD, Javier Bolanos Meade, MD, Christopher Gocke, Constance Griffin, M.D., Richard J. Jones
Journal: Blood
Blood (2011) 118 (21): 4598.
https://doi.org/10.1182/blood.V118.21.4598.4598
Published: 2011
Journal Articles

K562/GM-CSF Immunotherapy as a “Booster” Vaccine In Chronic Myeloid Leukemia

Eunpi Cho, M.D., Hyam I. Levitsky, Jeanne Kowalski, PhD, Hua-Ling Tsai, MS, Lu Qin, Research, A, Christopher Gocke, B. Douglas Smith, MD
Journal: Blood
Blood (2010) 116 (21): 4347.
https://doi.org/10.1182/blood.V116.21.4347.4347
Published: 2010
Journal Articles

IgVH Mutational Status Is Prognostic In 13q Deletion (del) Chronic Lymphocytic Leukemia (CLL)

Douglas Edward Gladstone, Lode J. Swinnen, MD, Christopher Gocke, Amanda Blackford, Constance A. Griffin, Richard J. Jones, MD
Journal: Blood
Blood (2010) 116 (21): 2419.
https://doi.org/10.1182/blood.V116.21.2419.2419
Published: 2010
Journal Articles

Immune Recovery after Timed Sequential Therapy in Acute Myelogenous Leukemia: Discordant Recovery of Naïve T Lymphocytes and Antigen Driven Regulatory T Cells.

Allan D. Hess, PhD, Christian Meyer, Christopher Thoburn, Ferdynand Kos, Christopher Gocke, Hyam Levitsky, Judith Karp
Journal: Blood
Blood (2008) 112 (11): 947.
https://doi.org/10.1182/blood.V112.11.947.947
Published: 2008
Journal Articles

Characterization of Immune Reconstitution Following High Dose Chemotherapy in Acute Myeloid Leukemia.

Christian F. Meyer, MD, PhD, Christopher Thoburn, Ferdynand Kos, PhD, Christopher Gocke, MD, Hyam I. Levitsky, MD, Janet A. Briel, Allan Hess, PhD, Judith E. Karp, MD
Journal: Blood
Blood (2007) 110 (11): 3888.
https://doi.org/10.1182/blood.V110.11.3888.3888
Published: 2007
Journal Articles

Clonal Heavy and Light Chain Immunoglobulin DNA in Plasma/Serum of AIDS Lymphoma Patients.

Nina D. Wagner-Johnston, MD, Dilber Nurmemet, MD, Christopher Gocke, MD, Lan Lin, MD, PhD, Victor M. Lemas, PhD, Otoniel Martinez-Maza, PhD, Richard F. Ambinder, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1579.
https://doi.org/10.1182/blood.V110.11.1579.1579
Published: 2007
Journal Articles

Clonotypic B Cells Circulate in Hodgkin’s Lymphoma (HL).

Richard J. Jones, MD, Lan Lin, M.D., Christopher Gocke, M.D., Kortney Hensley, Mark Siedner, James P. Barber, Yvette Kasamon, M.D., Richard F. Ambinder, M.D., Ph.D, William Matsui, M.D.
Journal: Blood
Blood (2006) 108 (11): 470.
https://doi.org/10.1182/blood.V108.11.470.470
Published: 2006
Journal Articles

Novel Retinoic Acid Metabolism Blocking Agents (RAMBAs) Induce Differentiation in ATRA Resistant Cell Line: Potential New Theraputics for Acute Promyleocytic Leukemia (APL).

Kavita B. Kalra, MD, Xiangfei Cheng, MD, PhD, Marion Womak, Christopher Gocke, MD, Jyoti B. Patel, PhD, Vincent C.O. Njar, PhD, Naoko Takebe, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 746.
https://doi.org/10.1182/blood.V106.11.746.746
Published: 2005